Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS National Framework for Golimumab Injection commencing 1st November 2025
Offer reference number: CM/TNS/25/5724
Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Janssen Cilag Ltd | 01027904 | £60,000,000 | 1 lot Lot 1 | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| MERCURY PHARMACEUTICALS LIMITED | 02619880 | £60,000,000 | 1 lot Lot 1 | - |
| ORIFARM UK LTD | 10015046 | £60,000,000 | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Nov 2025 – Oct 2026 | £107,912,000 £60,000,000 initial term | 3 | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| Janssen Cilag Ltd | Lot 1 | Won |
| MERCURY PHARMACEUTICALS LIMITED | Lot 1 | Won |
| ORIFARM UK LTD | Lot 1 | Won |
Weightings from the notice.
Government spending data: These suppliers have received £40,966,168 in 1,205 payments (over £25k) from Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust, Worcestershire Acute Hospitals NHS Trust, United Lincolnshire Hospitals NHS Trust, Maidstone and Tunbridge Wells NHS Trust and 14 more public bodies (2018-06-22 to 2026-03-31).